Free Trial

Clarkston Capital Partners LLC Has $80.89 Million Stock Position in Envista Holdings Corporation $NVST

Envista logo with Medical background

Key Points

  • Clarkston Capital Partners LLC increased its stake in Envista Holdings Corporation by 9.3%, owning 4,686,747 shares valued at approximately $80.9 million.
  • Envista reported a quarterly earnings per share (EPS) of $0.26, exceeding analyst expectations of $0.24, with revenues reaching $682.1 million.
  • The stock has a consensus rating of "Hold" from analysts, with a median price target of $20.92.
  • Five stocks to consider instead of Envista.

Clarkston Capital Partners LLC increased its stake in Envista Holdings Corporation (NYSE:NVST - Free Report) by 9.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,686,747 shares of the company's stock after buying an additional 398,672 shares during the quarter. Envista comprises 1.6% of Clarkston Capital Partners LLC's portfolio, making the stock its 23rd largest position. Clarkston Capital Partners LLC owned about 2.77% of Envista worth $80,893,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. grew its position in Envista by 214.4% in the first quarter. UMB Bank n.a. now owns 2,094 shares of the company's stock valued at $36,000 after acquiring an additional 1,428 shares in the last quarter. Palouse Capital Management Inc. grew its holdings in Envista by 14.4% during the 1st quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company's stock valued at $163,000 after purchasing an additional 1,186 shares in the last quarter. FourThought Financial Partners LLC purchased a new stake in Envista during the 1st quarter worth $180,000. Vestcor Inc acquired a new position in Envista in the 1st quarter worth $211,000. Finally, Tower Research Capital LLC TRC boosted its position in Envista by 51.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company's stock valued at $213,000 after buying an additional 3,751 shares during the last quarter.

Analyst Upgrades and Downgrades

NVST has been the topic of several recent analyst reports. Wall Street Zen upgraded Envista from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Wells Fargo & Company raised their price target on shares of Envista from $17.00 to $19.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. Baird R W raised shares of Envista from a "hold" rating to a "strong-buy" rating in a report on Tuesday, May 27th. Stifel Nicolaus raised their price objective on shares of Envista from $24.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Finally, Morgan Stanley upped their target price on shares of Envista from $16.00 to $17.00 and gave the company an "equal weight" rating in a research note on Friday, August 1st. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Envista presently has an average rating of "Hold" and an average target price of $20.92.

View Our Latest Analysis on NVST

Envista Trading Up 1.0%

Shares of NVST stock traded up $0.21 during trading hours on Tuesday, reaching $21.33. 281,678 shares of the stock traded hands, compared to its average volume of 2,550,115. Envista Holdings Corporation has a 1-year low of $14.22 and a 1-year high of $23.00. The business has a fifty day moving average price of $20.08 and a 200 day moving average price of $18.57. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $3.54 billion, a PE ratio of 66.66, a PEG ratio of 1.16 and a beta of 1.00.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. Envista had a net margin of 2.11% and a return on equity of 4.84%. The firm had revenue of $682.10 million for the quarter, compared to the consensus estimate of $638.21 million. During the same period in the previous year, the firm posted $0.11 earnings per share. The firm's revenue was up 7.7% on a year-over-year basis. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. On average, equities research analysts forecast that Envista Holdings Corporation will post 1 EPS for the current year.

Envista Profile

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Further Reading

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.